TROBALT 100 MG
Country: Iżrael
Lingwa: Ingliż
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
RETIGABINE 100 MG
Disponibbli minn:
GLAXO SMITH KLINE (ISRAEL) LTD
Kodiċi ATC:
N03AX21
Għamla farmaċewtika:
FILM COATED TABLETS
Rotta amministrattiva:
PER OS
Manifatturat minn:
GLAXO WELLCOME SA, SPAIN
Grupp terapewtiku:
RETIGABINE
Indikazzjonijiet terapewtiċi:
Trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.
Data ta 'l-awtorizzazzjoni:
2012-11-01
